欧洲内分泌学会与内分泌学会联合临床指南:糖皮质激素诱导的肾上腺功能不全的诊断与治疗
该指南由欧洲内分泌学会与内分泌学会联合制定,针对长期接受糖皮质激素治疗、存在糖皮质激素诱导的肾上腺功能不全风险的人群,提供诊断与治疗指导。指南强调风险与剂量、疗程、效力、给药途径及个体易感性相关,并给出减量策略与患者教育管理建议。
要点
- 长期糖皮质激素治疗者存在糖皮质激素诱导的肾上腺功能不全风险。
- 风险取决于剂量、疗程、效力、给药途径及个体易感性。
- 减量时超生理范围可较快,生理剂量阶段应减慢。
核心结论
- 该首部欧洲内分泌学会与内分泌学会联合临床实践指南为糖皮质激素诱导的肾上腺功能不全这一临床相关问题提供指导,以帮助参与慢性糖皮质激素治疗患者管理的临床医生。
研究设计与样本
- 由欧洲内分泌学会与内分泌学会联合制定的临床实践指南。
主要发现
- 糖皮质激素广泛用作抗炎和免疫抑制剂,导致至少1%的人群使用长期糖皮质激素治疗,面临糖皮质激素诱导的肾上腺功能不全风险。
- 该风险取决于糖皮质激素的剂量、疗程和效力、给药途径及个体易感性。
- 糖皮质激素减量在超生理范围可较快,在生理性糖皮质激素剂量时后续减量应较慢。
- 停止糖皮质激素治疗后下丘脑-垂体-肾上腺轴抑制的程度和持续时间取决于总体暴露,且肾上腺功能的恢复个体间差异很大。
临床怎么用
- 一旦发生或怀疑糖皮质激素诱导的肾上腺功能不全,需要对受影响患者进行仔细的教育和管理。
- 当出现糖皮质激素撤退症状且与肾上腺功能不全症状重叠时,糖皮质激素减量可能具有挑战性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glucocorticoids are widely prescribed as anti-inflammatory and immunosuppressive agents. This results in at least 1% of the population using chronic glucocorticoid therapy, being at risk for glucocorticoid-induced adrenal insufficiency. This risk is dependent on the dose, duration and potency of the glucocorticoid, route of administration, and individual susceptibility. Once glucocorticoid-induced adrenal insufficiency develops or is suspected, it necessitates careful education and management of affected patients. Tapering glucocorticoids can be challenging when symptoms of glucocorticoid withdrawal develop, which overlap with those of adrenal insufficiency. In general, tapering of glucocorticoids can be more rapidly within a supraphysiological range, followed by a slower taper when on physiological glucocorticoid dosing. The degree and persistence of HPA axis suppression after cessation of glucocorticoid therapy are dependent on overall exposure and recovery of adrenal function varies greatly amongst individuals. This first European Society of Endocrinology/Endocrine Society joint clinical practice guideline provides guidance on this clinically relevant condition to aid clinicians involved in the care of patients on chronic glucocorticoid therapy.
引用
- Beuschlein F, Else T, Bancos I, et al. European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency. J Clin Endocrinol Metab. 2024. PMID: 38724043. doi:10.1210/clinem/dgae250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。